New Webinar on Cancer Therapeutics and Their Risk to Corneal and Anterior Segment Health
A new webinar sponsored by the ASCRS Cornea Clinical Committee focuses on new cancer therapeutics and their effect on corneal and anterior segment health.
In “Antibody Drug Conjugates—An Emerging Class of Cancer Therapeutics Which Pose Risks to Corneal and Anterior Segment Health,” moderators Naveen Rao, MD, and Winston Chamberlain, MD, along with speakers Kamran Riaz, MD, Stella Kim, MD, and Farooq Asim, MD, discuss just what antibody drug conjugates are and what they’re used for. The faculty then reviews the possible complications and adverse reactions within the anterior segment that are associated with these drugs. They also provide a communication algorithm with the oncologist, including considerations for dose or frequency changes.
This webinar is approved for 1.5 AMA PRA Category 1 CreditsTM. Access the educational program here.
Don’t Wait to Register—Tier 2 Deadline This Friday
Onsite registration will be available for the ASCRS Annual Meeting, taking place April 25–28 in Los Angeles, California, but don’t wait until then to save your seat. Register before the April 4, tier 2 pricing deadline. After this date, the cost to attend will go up.
Register now for:
- Physician-designed education, tailored for anterior segment ophthalmologists
- The latest innovations and insights from experts and industry in a dynamic setting
- Focused connection unique to a subspecialty meeting
Attendees of the ASCRS Annual Meeting expand their networks, collaborate, earn CME, and bring back actionable knowledge and pearls to improve their outcomes and, ultimately, patient care.
Shape the Financial Future of Ophthalmology | SightLine at ASCRS
Strategize and execute a vision for the sustained financial health of ophthalmology at the new SightLine at ASCRS meeting, taking place Thursday, April 24 ahead of the 2025 ASCRS Annual Meeting.
The detailed agenda and faculty have been announced for this new meeting, which is an initiative of the American Society of Cataract and Refractive Surgery and the American Society of Ophthalmic Administrators where attendees will gain an understanding of the challenges affecting all areas of commercial ophthalmology and participate in the discussion and action that will ultimately lead to stronger financial performance in this space.
To forge a successful financial future for ophthalmology, SightLine at ASCRS needs input from all stakeholders in commercial ophthalmology—industry, physicians, and administrators are encouraged to attend.
Catch Up on These Special Member Messages
In honor of the 50th anniversary of ASCRS, member ophthalmologists from the 50 states are sending in their perspectives on the Society, sharing its impact on their career, and talking about its influence on the specialty as a whole.
Stay tuned each week through April 2025 for a new perspective.
This week’s perspective comes from Sumit "Sam" Garg, MD, from Maine. Watch his video here.
Important Resources
- ASCRS Live!: 2025 programming has begun
- SightLine at ASCRS: April 24, 2025 | Los Angeles, California
- Business of Interventional Glaucoma: April 24, 2025 | Los Angeles, California
- ASCRS Annual Meeting: April 25–28, 2025 | Los Angeles, California
- CME 24/7: Your source for the latest online CME from ASCRS; member login required
- Calculators and Tools: Essential tools for your practice
|
|
